FILTER RECORDS BY
Nettleton T (1722)
Part of a letter from Dr. Nettleton, physician at Halifax, to Dr. Jurin, R. S. Sec concerning the inoculation of the small pox, and the mortality of that distemper in the natural way. Philosophical Transactions of the Royal Society of London (1722-1723) 32:209-212.
View
Massey I (1723)
A short and plain account of inoculation. With some remarks on the main argument made use of to recommend that practice, by Mr. Maitland and others. To which is added, a letter to the learned James Jurin, M.D.R.S. Secr. Col. Reg. Med. Lond. Soc. London: W. Meadows.
View
Jurin J (1724)
A letter to the learned Dr. Caleb Cotesworth, F. R. S. of the College of Physicians, London, and physician to St. Thomas's Hospital; containing a comparison between the danger of the natural small pox, and that given by inoculation. Philosophical Transactions of the Royal Society of London (1722 - 1723), 32:213-227.
View
Boylston Z (1726)
Historical account of the small-pox inoculated in New-England, upon all sorts of persons, whites, blacks, and of all ages and constitutions. London: Printed for S. Chandler.
View
Cassem Algaida Aga (1729)
Paper relating to the inoculation of the small-pox, as it is practised in the Kingdoms of Tripoli, Tunis, and Algier. In: Scheuchzer JG. An account of the success of inoculating the small-pox in Great Britain, for the years 1727 and 1728. London: J. Peele, pp 61-63.
View
Scheuchzer JG (1729)
An account of the success of inoculating the small-pox in Great Britain, for the years 1727 and 1728: With a comparison between the mortality of the natural small-pox, and the miscarriages in that practice; as also some general remarks on its progress. London: J.Peele.
View
de la Condamine C-M (1754)
Mémoire sur l'inoculation de la petite vérole. Lu a l'assemblée publique de l'Académie royale des sciences, le mercredi 24 avril 1754. Paris: Durand.
View
Franklin B (1759)
Some account on the success of inoculation for the small-pox in England and America. London: W Strahan.
View
Watson W (1768)
An account of a series of experiments, instituted with a view of ascertaining the most successful method of inoculating the smallpox. London: J Nourse.
View
Gregory J (1772)
Lectures on the duties and qualifications of a physician. London: Strahan and Cadell. (new ed.) Edinburgh: Creech.
View
Haygarth J (1784)
An inquiry into how to prevent smallpox. Chester and London.
View
Black W (1789)
An arithmetical and medical analysis of the diseases and mortality of the human species. London: J Johnson.
View
Haygarth J (1793)
Sketch of a plan to exterminate the casual smallpox from Great Britain; and to introduce general inoculation. London: J Johnson
View
Sutton D (1796)
The Inoculator; or Suttonian system of inoculation, fully set forth in a plain and familiar manner. London: Printed for the author.
View
Jenner E (1798)
An enquiry into the causes and effects of the variolae vaccinae. London: S Low.
View
Jenner E (1801)
The origin of the vaccine inoculation. Printed by DN Shury, Berwick Street, Soho.
View
Pearson G, Nihell L, Nelson T, Keate T, Forster T, Carpue JC, Doratt J, Rivers F, Brand EA, de Bruyn P, Heaviside J, Payne T, Sancho W (1805)
Original Vaccine Pock Institution. Edinburgh Medical and Surgical Journal 1:513-515.
View
Bigelow J (1835)
A discourse on self-limited diseases, delivered before the Massachusetts Medical Society at their annual meeting, May 27, 1835. Boston: Nathan Hale p 8-10.
View
Pasteur L (1881)
Compte rendu sommaire des expériences rates á Pouilly-le-Fort, prés Melun, sur la vaccination charbonneuse [A summary account of experiences at Pouilly-le-Fort, near Mélun, on anthrax vaccination]. Comptes rendus de l'Académie des Sciences 92: 1378-1383.
View
Bettencourt R, Serrano J-A (1891)
Un cas de myxœdème (cachexie pachydermique) traité par la greffe hypodermique du corps thyroïde d’un mouton. [A case of myxœdema (pachydermous cachexia) treated with hypodermic transplant of sheep thyroid gland]. Compte rendu de la 19eme session de l‘Association française our l’avancement des sciences, Limoges, 1890, pp 683-690.
View
Murray GR (1891)
Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. BMJ 2:796-797.
View
Behring EA, Boer NN, Kossel H (1893)
Zur Behandlung diphtheriekranker Menschen mit Diphtherieheilserum [On the treatment of diphtheria patients with curative diphtheria serum]. Deutsche Medicinische Wochenschrift 17:389-39.
View
Roux E, Martin L, Chaillou A (1894)
Trois cent cas de diphthérie traité par le serum antidiphthérique. Annales de l’Institut Pasteur 8:640-661.
View
Brown EH (1896)
Cholera and its treatment by preventive inoculation in the Darbhanga Jail. Indian Medical Gazette, July, 247-250.
View
Haffkine WM (1896)
Correspondence: Explanation of his inoculation report forms. Indian Medical Gazette 31:189-190.
View
Pregl F (1896)
Zwei weitere ergographische Versuchsreihen über die Wirkung orchistischen Extraktes [Two further ergographic experimental series on the effects of testicular extracts]. Archiv für die gesamte Physiologie 62:379-399.
View
Winters JE (1896)
Clinical observations upon the use of antitoxin in diphtheria: A report of personal investigation of this treatment in the principal fever hospitals of Europe during the summer of 1895. Medical Record 49:877-893.
View
Heiberg P (1897)
Studier over den statistiske undersøgelsesmetode som hjælpemiddel ved terapeutiske undersøgelser [Studies on the statistical study design as an aid in therapeutic trials]. Bibliotek for Læger 89:1-40.
View
Fibiger J (1898)
Om serumbehandling af difteri [On treatment of diphtheria with serum]. Hospitalstidende 6:309-325.
View
Clemow (1899)
Yersin serum treatment of plague. BMJ 1:48.
View
Cotton FJ (1899)
The Present Status of the Antistreptococcic Serum. New England Journal of Medicine 140:105-109. DOI: 10.1056/NEJM189902021400501
View
Haffkine WM (1900)
On preventive inoculation. Proceedings of the Royal Society of London 65:252-271.
View
Choksy NH (1900)
Professor Lustig’s plague serum. Lancet 2:291-292.
View
Park WH (1900)
Use of diphtheria antitoxin in the treatment and prevention of diphtheria. JAMA 34: 902-904.
View
Park WH (1900)
The quantity of diphtheria antitoxin required in the treatment of diphtheria. Archives of Paediatrics 17:823-827.
View
Lustig A, Galeotti G (1901)
The prophylactic and curative treatment of plague. BMJ 1:206-208.
View
Choksy NH (1901)
Plague treatment with Lustig’s serum. Indian Medical Gazette 36:154–155.
View
Indian Plague Commission (1902)
Serum therapeutics. Investigations conducted by the commissioners. BMJ 1:1159-1160.
View
Polverini G (1903)
Serumtherapie gegen Beulenpest Muenchener Medizinische Wochenschrift 50:649-651.
View
Pearson K (1904)
Report on certain enteric fever inoculation statistics. BMJ 3:1243-1246.
View
Bannerman WB (1905)
Introduction. In: Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 1-27.
View
Haffkine WM, West WG (1905)
Report on a series of 70 cases of plague treated with Brazil’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 47-59.
View
Haffkine WM (1905)
Report on a series of 484 cases of plague treated with Lustig’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 27-36.
View
Haffkine WM, Costello CT (1905)
Report on a series of 110 cases of plague treated with Terni’s anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 37-46.
View
Rosenbach O (1905)
Die Diagnose als ätiologischer Factor [The diagnosis as a factor in aetiology]. Zeitschrift fur klinische Medicin 56:232-240.
View
West WG (1905)
Report on a series of 68 cases of plague treated with Roux’ anti-plague serum. In: Bannerman WB, ed. Serum-therapy of plague in India. Scientific Memoirs by Officers of the Medical and Sanitary Departments of the Government of India. Calcutta, India: Office of the Superintendent of Government Printing, pp 60-7
View
Choksy NH (1908)
On recent progress in serum-therapy of plague. BMJ 1:1282-1284.
View
Freeman J (1910)
Vaccine therapy. Proceedings of the Royal Society of Medicine 3:97-101.
View
Advisory Committee on Plague Investigations in India (1912)
The serum treatment of human plague. Journal of Hygiene. Plague Supplement II, LVI:326-39.
View
Freeman RG (1912)
Serum treatment of pneumonia. JAMA 59:140.
View
Park WH (1912)
The role of animal experimentation in the discoveries leading to our present knowledge of the etiology, prevention and cure of diphtheria. JAMA 53:453-459.
View
Barnes HL (1912)
Report of 150 cases of pulmonary tuberculosis treated with tuberculin. JAMA 59:332-33.
View
Rosenow EC, Hektoen L (1913)
Treatment of pneumonia with partially autolyzed pneumococci. JAMA 61:2203-4.
View
Wright AE (1914)
On pharmaco-therapy and preventive inoculation applied to pneumonia in the African Native. London: Constable, p 84.
View
Wright AE, Morgan WP, Colebrook L, Dodgson RW (1914)
Observations on prophylactic inoculation against pneumococcus infections, and on the results which have been achieved by it. Lancet 1:87-95
View
Goadby K (1916)
An inquiry into the natural history of septic wounds. Lancet 188: 89-95.
View
Leake JP (1917)
Bacterial vaccine therapy. JAMA 69:631-632.
View
Von Sholly AI, Blum J, Smith L (1917)
The therapeutic value of pertussis vaccine in whooping cough. JAMA 68:1451-1456.
View
Bingel A (1918)
Über Behandlung der Diphtherie mit gewöhnlichem Pferdeserum [On the treatment of diphtheria with normal horse serum]. Deutsches Archiv für Klinische Medizin 125:284-332.
View
Kyes P (1918)
The treatment of lobar pneumonia with an anti-pneumococcus serum. Journal of Medical Research 38:495-501.
View
McCoy GW, Murray VB, Teeter AL (1918)
The failure of a bacterial vaccine as a prophylactic against influenza. JAMA 71:1997.
View
Lees D (1919)
Detoxicated vaccines in the treatment of gonorrhœa: the value of the complement-deviation test in controlling the treatment and estimating its therapeutic effect. Lancet 1:1107-1111.
View
Leighton Kesteven H (1919)
A study of epidemic influenza in Australia. Lancet 2:1189-91.
View
Mcguire LW, Redden WR (1919)
Treatment of Influenzal pneumonia by the use of convalescent human serum, Second report. JAMA 72:709-713. doi:10.1001/jama.1919.02610100017007
View
Gray AW (1920)
Antipneumococcus serum (Kyes’s) in the treatment of pneumonia. American Journal of Medical Sciences 159:885-891.
View
Banting FG, Best CH, Collip JB, Campell WR, Fletcher AA (1922)
Pancreatic extracts in the treatment of diabetes mellitus. Canadian Medical Association Journal 12: 141 - 146.
View
Cecil RL, Larsen NP (1922)
Clinical and bacteriologic study of one thousand cases of lobar pneumonia. JAMA 79:343-349.
View
Greenwood M (1924)
Is the statistical method of any value in medical research? Lancet 2: 153-158.
View
Locke EA (1924)
The serologic treatment of lobar pneumonia. Boston Medical and Surgical Journal 190:196-203.
View
Lewis S (1925)
Arrowsmith. New York: Collier.
View
Malaria Commission of the Health Organisation (1925)
Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.
View
Oliver WW, Stoller EA (1925)
Notes on the therapeutic value of pneumococcus antibody solution subcutaneously administered in lobar pneumonia. Archives of Internal Medicine 35:267-286.
View
Park WH (1925)
Scarlet fever: etiology, prevention by immunization, and antitoxic treatment. JAMA 85:1180-1186.
View
Swellengrebel NH (1925)
A summary of the more important facts on adult anophelines and their larvae observed by us or brought to our notice duing our tour through eastern Europe and Italy (May-September 1924). pp183-190. In: Malaria Commission of the Health Organisation (1925). Report on its tour of investigation in certain European countries in 1924. Geneva: League of Nations. C.H. 273.
View
Wagner-Jauregg J (1926)
Die moderne Therapie der Neurolues [On modern therapy for neurosyphilis]. Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Achtundreissigster Kongress. München: Bergmann, p 34-62.
View
Ferguson FR, Davey AFC, Topley WWC (1927)
The value of mixed vaccines in the prevention of the common cold. Journal of Hygiene 26:98-109.
View
Gordon E (1927)
Treatment of scarlet fever with streptococcus antitoxin. JAMA 88:382-5.
View
Harries (1927)
Discussion on the serum treatment of scarlet fever. Proceedings of Royal Society of Medicine 20:1175–1176.
View
Symmers D, Lewis KM (1927)
The antitoxin treatment of erysipelas: observations in one hundred and thirty-one patients at Bellevue Hospital. JAMA 89:880-2.
View
Bullowa JGM (1928)
Use of antipneumococcic refined serum in lobar pneumonia: data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 90: 1354-1358.
View
Bullowa JGM (1928)
The control. Contribution to a symposium on the use of antipneumococcic refined serum in lobar pneumonia, 15 December 1927. Bulletin of the New York Academy of Sciences 4:339-343.
View
Cecil RL, Sutliff WD (1928)
The treatment of lobar pneumonia with concentrated anti-pneumococcus serum. JAMA 91:2036-2040.
View
Cecil RL (1928)
Specific treatment of lobar pneumonia. Archives of Internal Medicine 41:295-335.
View
Ferry NS, Gordon EJ, Munro FW, Steele AH, Fisher LW (1928)
Clinical results with measles streptococcus toxin and antitoxin. JAMA 91:1277-1280.
View
McCann WS (1928)
The serum treatment of erysipelas. JAMA 91:78-81.
View
Park WH, Bullowa JGM, Rosenbluth NM (1928)
The treatment of lobar pneumonia with refined specific antibacterial serum. JAMA 91:1503-1508.
View
Ross WC, Bagchi KN , Roy BC (1928)
The bacteriophage in cholera. Indian Journal of Medical Research 15:965-968.
View
Bullowa JGM (1929)
The serum treatment and its evaluation in lobar pneumonia. Bulletin of the New York Academy of Medicine 5:328-362.
View
Joe A, Swyer R (1929)
A study of passive immunisation in scarlet fever. Lancet 1:177-179.
View
Benson WT (1930)
The treatment of erysipelas with vaccines. Lancet 2:1286-289.
View
Cecil RL, Plummer N (1930)
Pneumococcus type I pneumonia - a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 95:1547-1553.
View
Finland M (1930)
The serum treatment of lobar pneumonia. New England Journal of Medicine 202:1244-1247.
View
Iversen P (1930)
Nogle bemærkninger om komplikationerne til parotitis epidemica og forsøg paa behandling med rekonvalescentserum [Treatment of complications of epidemic mumps with the serum of convalescents]. Ugeskrift for Læger 92:167-169.
View
Kauders O (1930)
Ueber Nachbehandlung nach Malariatherapie [On the management of patients after malaria therapy]. Deutsche Medizinishe Wochenshcrift 61:400-401.
View
Physicians to the Royal Infirmary, Edinburgh (1930)
A report on lobar pneumonia: treatment by concentrated antiserum. Lancet 2:1390-1394.
View
Koenigsberger E (1931)
Die Behandlung der malignen Diphtherie, nach Erfahrungen in Berlin und Kopenhagen [Treatment of malignant diphtheria based on experiences in Berlin and Copenhagen]. Deutsche Medizinische Wochenschrift 57:842-845.
View
Naidu BPB, Mackie FP (1931)
The serum therapy of plague. Lancet 2:893-897.
View
Sutliff WD, Finland M (1931)
Type I lobar pneumonia treated with concentrated pneumococcic antibody (Felton). The clinical course. JAMA 96:1465-1469.
View
Swyer R (1931)
Antigenic properties of diphtheria toxoid-antitoxin floccules. Lancet 1:632-634.
View
Wagner-Jauregg J (1931)
Ueber die Infektionsbehandlung der progressiven Paralyse [On infection treatment of progressive paralysis]. Münchener Medizinische Wochenschrift 78:4-7.
View
Aldred-Brown GRP, Munro JMH (1932)
Autogenous urinary proteose in rheumatoid arthritis. Lancet 2:1211-1214.
View
Armstrong RR, Johnson RS (1932)
Treatment of lobar pneumonia by anti-pneumococcal serum. BMJ 2:662-65.
View
Cecil RL, Plummer N (1932)
Pneumococcus Type II pneumonia: a clinical and bacteriologic study of one thousand cases, with especial reference to serum therapy. JAMA 98:779-86.
View
Riding D, Corkhill NL (1932)
Prophylactic vaccination in epidemic meningococcal meningitis. Journal of Hygiene 32:258-267.
View
Hottinger A, Toepfer D (1933)
Über den Wert der Serumtherapie bei Diphtherie, insbesondere bei der malignen, toxischen form [On the value of serum therapy of diphtheria, particularly in its malignant, toxic form]. Zeitschrifte für Kinderheilkunde 54:505-529.
View
Kessel JF, Rose EJ (1933)
Bacteriophage Therapy in Bacillary Dysentery of the Flexner Type*†. Annals of Internal Medicine 6:1193-1199.
View
Macnamara J (1933)
Serum therapy in poliomyelitis. BMJ 1:526-8.
View
Sutliff WD, Finland M, Hunnicutt TN (1933)
Direct comparison between specific and nonspecific serum therapy for type 1 lobar pneumonia. Archives of Internal Medicine 51:435-446.
View
Bullowa JGM (1934)
Therapeutic pneumococcus Type VIII (Cooper) serum. JAMA 102: 1560-1561.
View
Medical Research Council Therapeutic Trials Committee (1934)
The serum treatment of lobar pneumonia. BMJ 1:241-245.
View
Fischer A (1934)
Human Convalescent Serum in the Treatment of Preparalytic Poliomyelitis. Am J Dis Child 48: 481-501.
View
McSweeny CJ (1935)
Clinical trials with a new antityphoid serum. Lancet 1:1095-1098.
View
Begg N, Coveney MF (1936)
Whooping-cough: value of a specific vaccine in treatment. Lancet 1:82-83.
View
Doull JA, Shibley GS, McClelland JE (1936)
Active immunization against whooping cough: interim report of the Cleveland experience. American Journal of Public Health 26:1097-1105.
View
Gilliam AG, Onstott RH (1936)
Results of field studies with poliomyelitis vaccine. American Journal of Public Health 26:113-118.
View
Hoyne AL (1936)
Intravenous treatment of meningococcic meningitis with Meningococcus antitoxin. JAMA 107:478-81.
View
Pasricha CL, de Monte AJH, O’Flynn EG (1936)
Bacteriophage in the treatment of cholera. Indian Medical Gazette 71:61-68.
View
Sutliff WD (1936)
Adequate tests of curative therapy in man. Annals of Internal Medicine 1936-1937;10:89-97.
View
Bullowa JGM (1937)
Serum therapy. In: Bullowa JGM. The management of the pneumonias. New York: Oxford University Press, pp 283-298.
View
Cookson H, Facey RV (1937)
Value of a specific serum in the treatment of typhoid fever. BMJ 1:1009-1012.
View
Cunningham AA (1937)
Vaccine treatment of measles. BMJ 1:1202-1203.
View
Pratt JP, Thomas WL (1937)
The endocrine treatment of menopausal phenomena. JAMA 109:1875-1880.
View
Diehl HS, Baker AB, Cowan DW (1938)
Cold vaccines: an evaluation based on a controlled study. Journal of American Medical Association 111:1168-1173.
View
Harrison WT, Franklin JP, Bell JA (1938)
Prophylactic value of a single dose of precipitated pertussis vaccine. Public Health Reports 53:793-796.
View
Lash AF (1938)
Concentrated streptococcus (hemolytic) antitoxic serum in puerperal fever: further therapeutic studies. JAMA 110:1988-91.
View
Nissen NI (1938)
Erfahrungen mit der Serumtherapie der kruppösen Pneumonie. [Experiences with serum therapy of pneumonia with croup]. Deutsche Medizinische Wochenschrift 64:221-225.
View
Orenstein AJ (1938)
Report for the year 1937. Health Department, Central Mining-Rand Mines Group, p 8.
View
Peters BA (1938)
A comparative test of natural and concentrated anti-toxin in treatment of malignant diphtheria. BMJ 2:344-346.
View
Kendrick P, Eldering G (1939)
A study in active immunization against pertussis. American Journal of Hygiene 29 Sec. B:133-153.
View
Murless BC (1939)
Effect of follicular hormone on menopausal flushes. Lancet 233:1205-1206.
View
Pasricha CL, de Monte AJH, Chatterjee BC, Mian AS (1939)
Treatment of cholera (A note on the results of treatment by different methods). Indian Medical Gazette 74:400-401.
View
Top FH, Young DC (1939)
Specific and non-specific serum treatment of scarlet fever. American Journal of Public Health 29:443-451.
View
Volini IF, Levitt RO (1939)
The treatment of Pneumococcic pneumonia with concentrated rabbit serum. JAMA 113: 1314-6.
View
Gregory KK, West EJ, Stevens RE (1940)
Epidemic cerebrospinal meningitis (meningococcic): the treatment of 113 patients with antimeningococcus serum, meningococcus antitoxin and sulfanilamide. JAMA 115:1091-5.
View
Sidell N, Abrams MI (1940)
Treatment of chronic arthritis. JAMA 144:1740-1742.
View
Bell JA (1941)
Pertussis prophylaxis with two doses of alum-precipitated vaccine. Public Health Reports 56:1535-1546.
View
Ewalt JR, Ebaugh FG (1941)
Treatment of dementia paralytica: A five year comparative study of artificial fever therapy and therapeutic malaria in two hundred and thirty-two cases. JAMA 116:2474-77.
View
Fleming JB (1941)
Treatment of diphtheria. BMJ 1:907.
View
Kaufman P (1941)
Studies on old age pneumonia. II. Prophylactic effect of pneumococcus polysaccharide against pneumonia. Archives of Internal Medicine 61:304-319.
View
Libertson W (1941)
A critical analysis of insulin therapy at Rochester State Hospital. Psychiatric Quarterly 15: 635-647.
View
Top FH, Young DC (1941)
The treatment of moderately severe scarlet fever: A study of alternate patients treated with sulfanilamide, convalescent serum and scarlet fever antitoxin. JAMA 117:2056-60.
View
Kendrick PL (1942)
Use of alum-treated pertussis vaccine, and alum-precipitated combined pertussis vaccine and diphtheria toxoid, for active immunization. American Journal of Public Health 32:615-626.
View
Kendrick PL (1943)
Field study of alum-precipitated combined pertussis vaccine and diphtheria toxoid for active immunization. American Journal of Hygiene 38:193-202.
View
Sigler LH, Tulgan J (1943)
Treatment of angina pectoris by testosterone propionate. New York State Journal of Medicine 43:1424-1428.
View
Boyd JSK, Portnoy B (1944)
Bacteriophage therapy in bacillary dysentery. Transactions of the Royal Society of Tropical Medicine and Hygiene 37:243-262.
View
Commission on Influenza (1944)
A clinical evaluation of vaccination against influenza. JAMA 124:982-985.
View
Wolman M (1944)
Treatment of typhus with anti-typhus horse serum. Lancet 2:210-12.
View
Wright J, Cruickshank R, Gunn W (1944)
The control of dust-borne streptococcal infection in measles wards. BMJ 1:611-614.
View
Bransby ER, Hunter JW, Magee HE, Milligan EHM, Rodgers TS (1944)
The influence of supplements of vitamins A, B1, B2, C, and D on growth, health and physical fitness. BMJ 1:77.
View
MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG (1945)
Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. Journal of Experimental Medicine 82:445-465.
View
Bahlke AM, Perkins JE (1945)
Gamma globulin in poliomyelitis. JAMA 129:1146-1150.
View
Gellis SS, Stokes J, Forster HW, Brother GM, Hall WM (1945)
The use of human immune serum globulin (gamma globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations II. Studies on treatment in an epidemic of infectious hepatitis. JAMA 128:1158-9.
View
Grossman EB, Stewart SG, Stokes J (1945)
Post-transfusion hepatitis in battle casualties: and a study of its prophylaxis by means of human immune serum globulin. JAMA 129:991-4.
View
Havens WP, Paul JR (1945)
Prevention of infectious hepatitis with gamma globulin. JAMA 129:270-272.
View
McFarlan AM, Topley E, Fisher M (1945)
Trial of whooping-cough vaccine in city and residential nursery groups. BMJ 2:205-208.
View
Rosenthal SR, Blahd M, Leslie EI (1945)
Ten years’ experience with BCG (experimental and clinical). Journal of Pediatrics 26:470-80.
View
Aronson JD, Palmer CE (1946)
Experience with BCG vaccine in the control of tuberculosis among North American Indians. Public Health Reports 61:802-820.
View
Levine MI, Sackett MF (1946)
Results of BCG vaccination in New York City. American Review of Tuberculosis 53:517-532.
View
Hirsh HL, Rotman-Kavka, G, Dowling HF, Sweet LK (1947)
Penicillin therapy of scarlet fever: comparison with antitoxin and symptomatic therapy. JAMA 133:657-61.
View
Robinson M (1947)
Hormonal treatment of deficient lactation. Lancet 2:90-92.
View
Bell JA (1948)
The epidemiological principles and procedures involved in a study of the prophylactic value of an alum-precipated mixture of diphtheria toxoid and pertussis vaccine. Thesis submitted to the School of Hygiene and Public Health of the Johns Hopkins University in conformity with the requirements for the Degree of Doctor of Public Health.
View
Bell JA (1948)
Diphtheria immunization use of an alum-precipitated mixture of pertussis vaccine and diphtheria toxoid. JAMA 137:1009-1016.
View
Bell JA (1948)
Pertussis immunization use of two doses of an alum-precipitated mixture of diphtheria toxoid and pertussis vaccine. JAMA 137:1276-1281.
View
Mellanby H, Andrewes CH, Dudgeon JA, Mackay DG (1948)
Vaccination against influenza A. Lancet 251:978-982.
View
Bingel A (1949)
Wirkt das Diphtherieheilserum bei der menschlichen Diphtheriekrankheit spezifisch durch seinen Antitoxingehalt oder unspezifisch [Does curative diphtheria serum act specifically through its anti-toxin content or non-specifically in human diphtheria]? Deutsche Medizische Wochenschrift 74:101-103.
View
Ferguson RG, Simes AB (1949)
BCG vaccination of Indian infants in Saskatchewan. Tubercle 30:5-11 30:5-11.
View
Kaufman P (1949)
Pneumonia in old age: active immunization against pneumonia with pneumococcus polysaccharide results of a six your study. Archives of Internal Medicine 79:518-531.
View
Appleby JC, Himmelweit F, Stuart-Harris CH (1951)
Immunization with influenza virus A vaccines. Comparision of intradermal and subcutaneous routes. Lancet 1:1384-1387.
View
Medical Research Council (1951)
The prevention of whooping-cough by vaccination. BMJ 1:1463-1471.
View
Hammon W, Coriell LL, Stokes J (1952)
Evaluation of red cross gamma globulin as a prophylactic agent for poliomyelitis: 1. Plan of controlled field tests and results of 1951 pilot study in Utah. JAMA 150:739-749.
View
Rheumatic Fever Working Party of the Medical Research Council of GB and the subcommittee of principal investigators of the American Council on Rheumatic Fever and Congenital Heart Disease, American Heart Association. (1955)
Treatment of acute rheumatic fever in children; a co-operative clinical trial of A.C.T.H., Cortisone, and Aspirin. BMJ 1:555-574
View
Bjerkelund CJ (1957)
The effect of long-term treatment with dicoumarol in myocardial infarction. A controlled clinical study. Acta Med Scand Suppl 330:1-212.
View
Gam F, Helles A, Andersen B (1977)
Hormonal treatment of climacteric complaints. A controlled, double-blind comparative study between 2 different types of sequential estrogen-gestagen preparations [in Danish]. Ugeskr Laeger 139:2808-12.
View
Foon KA, Smalley RV, Riggs CW, Gale RP (1983)
The role of immunotherapy in acute myelogenous leukemia. Arch Intern Med 143: 1726-1731
View
Yokley JM, Glenwick DS (1984)
Increasing the immunization of preschool children; An evaluation of applied community interventions. Journal of Applied Behavior Analysis 17:313-325.
View
Roifman CM, Levison H, Gelfand EW (1987)
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 329: 1075–1077.
View
Chalmers I, ed (1988)
The Oxford Database of Perinatal Trials. Oxford: Oxford University Press.
View
Chalmers I, Enkin M, Keirse MJNC (1989)
Effective care in pregnancy and childbirth. Oxford: Oxford University Press.
View
Gray R, Wheatley K (1991)
How to avoid bias when comparing bone marrow transplantation with chemotherapy. Proceedings of the International Course on Bone Marrow Transplantation in Children, 28 Nov-1 Dec 1990, Erice, Italy. Bone Marrow Transplantation 7, Suppl 3:9-12.
View
Sinclair JC, Bracken MB (1992)
Effective care of the newborn infant. Oxford: Oxford University Press.
View
Cochrane Pregnancy and Childbirth Group (1994)
The Cochrane Pregnancy and Childbirth Database. Oxford: Update Software
View
Stockwell MS, CaCamargo S, Ramakrishnan R, Holleran S, Findley SE, Kukafka R, Hofstetter AM, Fernandez N, Vawdrey DK (2015)
Registry-linked electronic influenza vaccine provider reminders: a cluster-crossover trial. Pediatrics. 135:e75-82.
View
Cohen D (2018)
Oxford TB vaccine study calls into question selective use of animal data. BMJ 360:j5845 doi: 10.1136/bmj.j5845
View
Show
Hróbjartsson A, Gøtzsche PC, Gluud C (1988).
The controlled clinical trial turns 100 years: Fibiger’s trial of serum treatment of diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2003).
Adolf Bingel (1879-1953), a member of the last generation of general internal physicians in Germany. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Huth EJ (2005).
Quantitative evidence for judgments on the efficacy of inoculation for the prevention of smallpox: England and New England in the 1700s. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Huth EJ (2006).
Benjamin Franklin’s (1706-1790), place in the history of medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Jefferson T (2006).
Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Marks HM† (2006).
The Kendrick-Eldering-(Frost) pertussis vaccine field trial. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Neuhauser D, Diaz M (2006).
Jesse GM Bullowa (1879-1943). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2008).
Zabdiel Boylston (1679/80-1766). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2008).
William Watson’s use of controlled clinical experiments in 1768. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW, Williams AE (2008).
Zabdiel Boylston’s evaluation of inoculation against smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Podolsky SH (2008).
Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Shannon H (2008).
A statistical note on Karl Pearson’s 1904 meta-analysis. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Stylianou C, Kelnar C (2008).
The introduction of successful treatment of diabetes mellitus with insulin. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2010).
Thomas Nettleton and the dawn of quantitative assessments of the effects of medical interventions. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Chalmers I (2010).
Joseph Asbury Bell (1904-1968). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Chalmers I (2010).
Joseph Asbury Bell and the birth of randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Gluud C (2010).
Danish contributions to the evaluation of serum therapy for diphtheria in the 1890s. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Klingberg MA (2010).
An epidemiologist’s journey from typhus to thalidomide, and from the Soviet Union to Seveso. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Löwy I (2010).
Martin Arrowsmith’s clinical trial: scientific precision and heroic medicine. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Morabia A (2010).
Edward Jenner’s 1798 report of challenge experiments demonstrating the protective effects of cowpox against smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Opinel A, Gachelin G (2010).
French 19th century contributions to the development of treatments for diphtheria. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Slater SD (2010).
The discovery of thyroid replacement therapy. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2010).
Towards endocrinology: Theodor Kocher’s 1883 account of the unexpected effects of total ablation of the thyroid. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2010).
Adolf Bingel’s blinded, controlled comparison of different anti-diphtheritic sera in 1918. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2010).
Emil Theodor Kocher (1841-1917). JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2011).
Observation and experimentation in developing ‘the Suttonian Method’ of inoculation. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Chalmers I, Dukan E, Podolsky SH, Davey Smith G (2011).
The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Fox DM (2011).
Systematic reviews and health policy: the influence of a project on perinatal care since 1988. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Gartlehner G, Stepper K (2011).
Julius Wagner-Jauregg: pyrotherapy, Simultanmethode, and ‘racial hygiene’. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Podolsky SH, Davey Smith G (2011).
Park’s story and Winters’ tale: alternate allocation clinical trials in turn of the Century America. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2012).
The origins of vaccination: no inoculation, no vaccination. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2012).
John Haygarth’s 18th century ‘Rules of Prevention’ for eradicating smallpox. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Boylston AW (2012).
The origins of inoculation. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Ramanna M (2014).
Nasarwanji Hormusji Choksy (1861-1939), a pioneer of controlled clinical trials. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Bird A (2018).
James Jurin and the avoidance of bias in collecting and assessing evidence on the effects of variolation. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Jefferson T (2019).
Sponsorship bias in clinical trials – growing menace or dawning realisation? JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Tröhler U (2020)
Probabilistic thinking and the evaluation of therapies, 1700-1900. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Gøtzsche PC (2021).
Citation bias: questionable research practice or scientific misconduct? JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Ritskes-Hoitinga M, Pound P (2022).
The role of systematic reviews in identifying the limitations of preclinical animal research, 2000 – 2022. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Chalmers I, Matthews R, Glasziou P, Boutron I, Armitage P† (2023).
Analysis of clinical trial by Treatment Allocated or by Treatment Received? Applying ‘the intention-to-treat principle’. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Nylenna, M (2023).
Paul Owren, Christopher Bjerkelund and the dawn of controlled trials in Norway. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P† (2023)
The differences and overlaps between ‘explanatory’ and ‘pragmatic’ controlled trials: a historical perspective. JLL Bulletin: Commentaries on the history of treatment evaluation.
View
Nothing found, please try resetting your search filters
